Review your content's performance and reach.
Become your target audience’s go-to resource for today’s hottest topics.
Understand your clients’ strategies and the most pressing issues they are facing.
Keep a step ahead of your key competitors and benchmark against them.
Articles: 1-10 of 215
USA - December 1 2023 In September, the Federal Circuit affirmed the PTAB on every issue in 8 (66.67%) cases on appeal from post-grant proceedings, including in two…
USA - November 6 2023 In September, the PTAB cancelled 460 (76.54%) instituted claims across 33 IPR and PGR Final Written Decisions, including decisions issued following…
USA - October 27 2023 In Hope Medical Enterprises Inc., v. Fennec Pharmaceuticals Inc., the Board's Final Written Decision (FWD) found that Petitioner had not…
USA - October 17 2023 In August, the Federal Circuit affirmed the PTAB on every issue in 9 (81.82%) cases on appeal from post-grant proceedings, including in four…
USA - September 20 2023 In Tokyo Ohka Koygo., Ltd. v. Fujifilm Electronic Materials U.S.A., Inc., PGR2022-00010, Paper 28 (P.T.A.B. May 31, 2023), the Patent Trial and…
USA - September 15 2023 In a series of inter partes review (“IPR”) proceedings between JSR Corporation and Cytiva Bioprocess R&D AB, the Patent Trial and Appeal Board…
USA - September 12 2023 In June, the Federal Circuit affirmed the PTAB on every issue in 16 (88.89%) cases on appeal from post-grant proceedings, including in five…
USA - September 8 2023 In Fusion Pharms., Inc. v. Univerität Heidelberg, IPR2023-00551, the Patent Trial and Appeal Board (“PTAB”) instituted inter partes review (“IPR”)…
USA - September 5 2023 In Roku, Inc., v. Universal Electronics, Inc., Petitioner-Appellant Roku challenged the Board’s Final Written Decision in an inter partes review…
USA - August 31 2023 The Patent Trial and Appeals Board (“PTAB” or the “Board”) granted Columbia’s motion for sanctions seeking attorneys’ fees and costs incurred since…